Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
SJR0.465
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.465 | Q3 | 58.3% | |
| 2024 | — | — | 0.263 | Q3 | 41.1% | |
| 2023 | — | — | 0.361 | Q3 | 54.5% | |
| 2022 | — | — | 0.280 | Q3 | 48.5% | |
| 2021 | — | — | 0.323 | Q3 | 53.6% | |
| 2020 | — | — | 0.296 | Q3 | 49.9% | |
| 2019 | — | — | 0.251 | Q3 | 46.6% | |
| 2018 | — | — | 0.284 | Q3 | 48.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1871-5230
ISSN
1875-614X
region
Middle East
coverage
2006-2026